Our suite of novel chemistry technologies bring the unprecedented levels of diversity in payloads which accelerate the targeted drug discovery
Our suite of novel chemistry technologies bring the unprecedented levels of diversity in payloads which accelerate the targeted drug discovery
Our core portfolio and research focus is tubulysin toolbox through diverse chemistry platform which has the game changer payloads for ADCs. We are also committed towards linker technologies and small molecule/peptide drug conjugates.